Cytokine responses to human immunodeficiency virus type I (HIV-1) induced by immunization with live recombinant canarypox virus vaccine expressing HIV-1 genes boosted by HIV-1SF-2 recombinant GP120

被引:11
|
作者
Gorse, GJ
Patel, GB
Mandava, MD
Arbuckle, JA
Doyle, TM
Belshe, RB
机构
[1] St Louis Univ, Sch Med, St Louis Dept Vet Affairs Med Ctr, St Louis, MO 63110 USA
[2] St Louis Univ, Sch Med, Div Infect Dis & Immunol, St Louis, MO 63110 USA
关键词
cell-mediated immunity; HIV-1; cytokines; vaccines;
D O I
10.1016/S0264-410X(00)00378-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Vaccine-induced T-cell memory for human immunodeficiency virus type 1 (HIV-1) was assessed by measuring HIV-1 antigen-stimulated cytokine secretion in 72 HIV-1-uninfected subjects, of whom 52 received live recombinant canarypox virus vaccine expressing HIV-1 env, gag, and protease gene products (vCP205) with or without HIV-1(SF-2) recombinant gp120 (SF-2 rgp120) subunit vaccine, and 20 the control. The vCP205 vaccine induced secretion of the Th1 cytokine, interferon-gamma, by peripheral blood mononuclear cells (PBMC) after in vitro stimulation with HIV-1 p24 and envelope glycoprotein. Immunization schedules with both vCP205 and SF-2 rgp120 subunit vaccines induced secretion of Th1 and Th2 cytokines by PBMC to HIV-1 envelope glycoprotein. Hence, vCP205 and SF-2 rgp170 subunit vaccines given together and in a prime-boost sequence appeared to induce a broader cytokine response pattern than vCP205 vaccine given alone. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1806 / 1819
页数:14
相关论文
共 50 条
  • [21] NEUTRALIZATION OF PRIMARY HIV-1 ISOLATES BY SERA FROM PRIMATES IMMUNIZED WITH RECOMBINANT HIV-SF2 GP120
    STEIMER, KS
    YOSHIYAMA, H
    MCCLURE, J
    HO, DD
    SCANDELLA, CJ
    HAIGWOOD, NL
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1993, 6 (06): : 684 - 684
  • [22] RESISTANCE OF CHIMPANZEES IMMUNIZED WITH RECOMBINANT GP120(SF2) TO CHALLENGE BY HIV-1(SF2)
    ELAMAD, Z
    MURTHY, KK
    HIGGINS, K
    COBB, EK
    HAIGWOOD, NL
    LEVY, JA
    STEIMER, KS
    AIDS, 1995, 9 (12) : 1313 - 1322
  • [23] Human immunodeficiency virus-1 (HIV-1) gp120 superantigen-binding serum antibodies - A host factor in homosexual HIV-1 transmission
    TownsleyFuchs, J
    Kam, L
    Fairhurst, R
    Gange, SJ
    Goodglick, L
    Giorgi, JV
    Sidell, N
    Detels, R
    Braun, J
    JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (08): : 1794 - 1801
  • [24] Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector
    David K. Clarke
    David Cooper
    Michael A. Egan
    R. Michael Hendry
    Christopher L. Parks
    Stephen A. Udem
    Springer Seminars in Immunopathology, 2006, 28 : 239 - 253
  • [25] Broad Immunogenicity of a Multigene, Multiclade HIV-1 DNA Vaccine Boosted with Heterologous HIV-1 Recombinant Modified Vaccinia Virus Ankara
    Sandstrom, Eric
    Nilsson, Charlotta
    Hejdeman, Bo
    Brave, Andreas
    Bratt, Goran
    Robb, Merlin
    Cox, Josephine
    VanCott, Thomas
    Marovich, Mary
    Stout, Richard
    Aboud, Said
    Bakari, Muhammad
    Pallangyo, Kisali
    Ljungberg, Karl
    Moss, Bernard
    Earl, Patricia
    Michael, Nelson
    Birx, Deborah
    Mhalu, Fred
    Wahren, Britta
    Biberfeld, Gunnel
    JOURNAL OF INFECTIOUS DISEASES, 2008, 198 (10): : 1482 - 1490
  • [26] Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector
    Clarke, David K.
    Cooper, David
    Egan, Michael A.
    Hendry, R. Michael
    Parks, Christopher L.
    Udem, Stephen A.
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 2006, 28 (03): : 239 - 253
  • [27] Antibody to human immunodeficiency virus type 1 (HIV-1) gp160 in mucosal specimens of asymptomatic HIV-1-infected volunteers parenterally immunized with an experimental recombinant HIV-1 IIIB gp160 vaccine
    Lambert, JS
    Viscidi, R
    Walker, MC
    Clayman, B
    Winget, M
    Wolff, M
    Schwartz, DH
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1997, 4 (03) : 302 - 308
  • [28] Involvement of interleukin-1β in the mechanism of human immunodeficiency virus type 1 (HIV-1) recombinant protein gp120-induced apoptosis in the neocortex of rat
    Bagetta, G
    Corasaniti, MT
    Berliocchi, L
    Nisticó, R
    Giammarioli, AM
    Malorni, W
    Aloe, L
    Finazzi-Agró, A
    NEUROSCIENCE, 1999, 89 (04) : 1051 - 1066
  • [29] THE SAFETY AND IMMUNOGENICITY OF A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) RECOMBINANT GP160 CANDIDATE VACCINE IN HUMANS
    DOLIN, R
    GRAHAM, BS
    GREENBERG, SB
    TACKET, CO
    BELSHE, RB
    MIDTHUN, K
    CLEMENTS, ML
    GORSE, GJ
    HORGAN, BW
    ATMAR, RL
    KARZON, DT
    BONNEZ, W
    FERNIE, BF
    MONTEFIORI, DC
    STABLEIN, DM
    SMITH, GE
    KOFF, WC
    ANNALS OF INTERNAL MEDICINE, 1991, 114 (02) : 119 - 127
  • [30] Salivary binding antibodies induced by human immunodeficiency virus type 1 recombinant gp120 vaccine
    Gorse, GJ
    Yang, EY
    Belshe, RB
    Berman, PW
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1996, 3 (06) : 769 - 773